Relaxant activity of methanolic extract from seeds of Peganum harmala on isolated rat aorta

Therapie

Volumn 57, Issue 3, 2002, Pages 236-241

  Berrougui, H ^a,b   Herrera Gonzalez, H G ^a   Marhuenda, E ^a   Ettaib, A ^a   Hmamouchi, M ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b Faculty of Pharmacy   (Morocco)

Author keywords

Antagonists; Endothelium; Peganum harmala; Phosphodiesterase; Rat aorta; Vasodilator

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CYCLIC AMP PHOSPHODIESTERASE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; NORADRENALIN; PEGANUM HARMALA EXTRACT; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; MALE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; AORTA, THORACIC; FEMALE; MALE; METHANOL; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PEGANUM; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; SOLVENTS; VASOCONSTRICTOR AGENTS;

EID: 0036588512     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hmamouchi M. Les plantes medicinales et aromatiques marocaines 1999; pp.35. Enigma ed, 9954-8007-0-0: 450
2. Chopra RN, Chopra IC, Handa KL, et al. Chopra's indigenous drugs of India 1958. 2nd edn Calcuttta: U.N. Dhur and Pvt. Ltd: 370
3. Kirtikar KR, and Basu BD. Indian medicinal plants 1935. vol. 1. 2nd ed Allahabad: Lalit Mohan Basu: 457
4. Bellakhdar J. La pharmacopée marocaine traditionnelle. Médecine arabe ancienne et savoirs populaires 1997. Paris: Ibis Press
5. Rashan LJ, Adaay MH, Al-khazraji ALT. Activity of the aqueous extract from the seeds of Peganum harmala. Fitopterapia 1989; LX, 4, 365-367
6. Prashanth D, and John S. Antibacterial activity of Peganum harmala. Fitoterapia 1999; 70: 438-439
7. Ross SA, Megalla SE, Bishay DW, et al. Studies for determining antibiotic substances in some Egyptian plants, Part II, Antimicrobial alkaloids from the seeds of Peganum harmala. L. Fitoterapia 1980; 51: 309-312
8. Bruinvels J. and Sourkes TL. Influence of drugs on the temperature lowering effect of harmaline. Eur J Pharmacol 1968; 4: 31-39
9. Abdelfattah AFM, Matsumoto K, Gammaz HAK, et al. Hypothermic effect of Harmala alkaloid in rats: involvement of serotonergic mechanism. Pharmacol Biochem Behav 1995; 52 (2): 421-426
10. Fuentes JA, and Longo VG. An investigation on the central effects of harmine, harmaline and related beta-carbolines. Neuropharmacology 1971; 10 (1): 15-23
11. O'Hearn E, and Molliver ME. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 1993; 55 (2): 303-310
12. Aarons DH, Rossi GV, Orzechowski RF. Cardiovascular actions of three harmala alkaloids: harmine, harmaline and harmalol. J Pharm Sci 1977; 66: 1244-1248
13. Herrera MD, Zarzuelo A, Jimenez J, et al. Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. Gen Pharmacol 1996; 27: 273-277
14. Antonia Noguera M and Pilar D'Ocon M. Evidence that depletion of internal calcium stores sensitive to noradrenaline elicits a contractile response dependent on extracellular calcium in rat aorta. Br J Pharmacol 1993; 110: 861-867
15. Linde C and Quast U. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta. Br J Pharmacol 1995; 115: 515-521
16. Schoeffter P, Lugnier C, Demesy WF, et al. Role of cyclic AMP and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem. Pharmacol 1987; 36: 3965-3972
17. Hardman JG. Cyclic nucleotides and regulation of vascular smooth muscle. J Cardiovasc Pharmacol 1984; 6: S639-S645
18. Ramón Sánchez de Rojas V, Somoza B, Ortega T, et al. Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata. Planta Medica 1998; 65: 234-238
19. Lee MW, and Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 1994; 267: C659-C678
20. Chun-Chao S, Su-Ying C, Guei-Jane W, et al. Vasorelaxant effect of Harman. Eur J Pharmacol 2000; 390: 319-325
21. 45Ca uptake in isolated rat vascular smooth muscle. Gen. Pharmacol 1992; 23: 601-605
22. Lorenz K, and Wells J. Potentiation of the effects of sodium nitroprusside and isoproterenol by selective phosphodiesterase inhibitors. Mol Pharmacol 1983; 23: 424-430.
23. Duarte J, Pérez-vizcaíno F, Torres AI, et al. Vasodilator effects of visnagin in isolated rat vascular smooth muscle. Eur J Pharmacol 1995; 286: 115-122
24. Adelstein RS, Conti MA, and Hathway DR. Phosphorylation of smooth muscle myosin light chain kinase by the catalytic submit of adenosine 3′-5′monophosphate-dependent protein kinase. Biol Chem 1978; 253: 8347-8350.
25. Adelstein RS, Conti MA, and Pato MD. Regulation of myosin light chain kinase by reversible phosphorylation and calcium-calmodulin. Ann NY Acad Sci 1980; 256: 142-150
26. Maria JMS, Francisco RC and Marcus RV. Effects of the water soluble fraction from leaves of Agreratum conyzoides on smooth muscle. Phytotherapy Research 2000; 14: 130-132
27. Duarte J, Pérez-vizcaíno F, Zarzuelo A, et al. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 1993a; 239: 1-7.
28. Duarte J, Pérez-vizcaíno F, Utrilla P, et al. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol 1993b; 24: 857-862